IGF-1 LR3 and MGF Interaction
IGF-1 LR3 and MGF have an interaction requiring monitoring for interaction with 90% confidence. Both target IGF-1 pathways; combining risks receptor overstimulation. Both compounds affect the blood vessels and pituitary, so monitoring these systems is recommended.
Compound Profiles
IGF-1 LR3
Modified Growth Factor Analog | Muscle Growth
Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.
View full profileMGF
Mechano Growth Factor | IGF-1 Splice Variant
Activates muscle satellite stem cells via receptor binding, stimulating MAPK/ERK signaling. Enhances protein synthesis and promotes muscle fiber repair.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take IGF-1 LR3 with MGF?
Yes, but with caution. Both target IGF-1 pathways; combining risks receptor overstimulation. Regular monitoring is advised.
Is IGF-1 LR3 and MGF safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.
What are the interactions between IGF-1 LR3 and MGF?
Both target IGF-1 pathways; combining risks receptor overstimulation. This assessment has 90% confidence and is based on documented research data.
How should I time IGF-1 LR3 and MGF?
IGF-1 LR3 has a half-life of 20-30 hours and MGF has a half-life of ~5-7 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.